Fu et al. (2024) have examined the role of IP6K1/5-IP7 in cardiac ischemia-reperfusion injury and found that inhibiting or deleting IP6K1 can reduce the severity of myocardial infarction via increasing adiponectin levels in plasma (79). Here, IP6K1 is linked to myocardial ischemia.